Patents for C07D 487 - Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups (57,272) |
---|
04/25/2013 | US20130102778 Process for the preparation of isoxazolyl- methoxy nicotinic acids |
04/25/2013 | US20130102777 PREPARATION OF 13-CYCLOHEXYL-3-METHOXY-6-[METHYL-(2--ETHYL)-CARBAMOYL]-7H-INDOLO-[2,1-a]-[2]-BENZAZEPINE-10-CARBOXYLIC ACID |
04/25/2013 | US20130102775 Photochromic material |
04/25/2013 | US20130102774 Thionation process and a thionating agent |
04/25/2013 | US20130102623 Tricyclic Compounds Having Cytostatic and/or Cytotoxic Activity and Methods of Use Thereof |
04/25/2013 | US20130102621 Novel condensed pyridine or condensed pyrimidine derivative, and medicinal agent comprising same |
04/25/2013 | US20130102620 Pyrazolopyrimidine derivative |
04/25/2013 | US20130102613 Treatment of cancer with tor kinase inhibitors |
04/25/2013 | US20130102599 Pyrazolo [4,3-c] cinnolin-3-one m1 receptor positive allosteric modulators |
04/25/2013 | US20130102587 New Enzyme Inhibitor Compounds |
04/25/2013 | US20130101622 Imidazoquinoxaline compounds as immunomodulators |
04/25/2013 | DE102012004736A1 New 4-amino-3-phenylamino-6-phenylpyrazolo(3,4-d)pyrimidine derivatives useful as a medicament for prophylactic- or therapeutic treatment of viral infections, preferably picornavirus infections and rhinovirus infections |
04/25/2013 | CA2852939A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
04/25/2013 | CA2852937A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
04/25/2013 | CA2852936A1 Substituted bicyclic aza-heterocycles and analogues as sirtuin modulators |
04/25/2013 | CA2852921A1 Treatment of cancer with tor kinase inhibitors |
04/25/2013 | CA2852615A1 Novel substituted imidazopyrimidines as gpbar1 receptor modulators |
04/25/2013 | CA2850440A1 Process for the preparation of isoxazolyl-methoxy-nicotinic acids |
04/24/2013 | EP2583970A1 Certain chemical entities, compositions and methods comprising imidazopyrimidines |
04/24/2013 | EP2582703A1 Heteroaryl imidazolone derivatives as jak inhibitors |
04/24/2013 | EP2582702A1 Pyrazolopyrimidine kinase inhibitors |
04/24/2013 | EP2582700A2 Respiratory formulations and compounds for use therein |
04/24/2013 | EP2240454B1 Mesoionic pesticides |
04/24/2013 | CN1802159B 2-phenoxy- and 2-phenylsulfomamide derivatives with CCR3 antagonistic activity for the treatment of asthma and other inflammatory or immunological disorders |
04/24/2013 | CN1653050B Opioid and opioid-like compounds and uses thereof |
04/24/2013 | CN103068828A Triazolopyrazine derivatives |
04/24/2013 | CN103068827A Fused heterocyclic derivatives as s1p modulators |
04/24/2013 | CN103059052A Rare-earth metal compound and synthetic process thereof |
04/24/2013 | CN103059042A Thiophene derivative and application thereof to medicine |
04/24/2013 | CN103059033A New method for preparing formyl-porphyrins |
04/24/2013 | CN103059032A Separation technology of cyclic dipeptide C3 contained in phellinus igniarius |
04/24/2013 | CN103059031A High-pressure reverse-phase preparation separation technology of cyclic dipeptide C7 contained in phellinus igniarius |
04/24/2013 | CN103059030A Pyrimidine compound with effect of adhesion kinase inhibition and preparation method and application thereof |
04/24/2013 | CN103059029A Hexahydro-pyrrole[2,3]indole compound and its preparation method and use in bactericidal activity |
04/24/2013 | CN103058891A Method for producing biruea and urotropine |
04/24/2013 | CN102153559B Novel method for synthesizing sitagliptin phosphate and derivative thereof |
04/24/2013 | CN101945875B Azaindolizines and methods of use |
04/24/2013 | CN101809021B Octahydro-pyrrolo[3,4-b]pyrrole N-oxides |
04/24/2013 | CN101720325B Antimicrobial ortho-fluorophenyl oxazolidinones for treatment of bacterial infections |
04/24/2013 | CN101611036B Novel tetracyclic inhibitors of cysteine proteases, the pharmaceutical compositions thereof and their therapeutic applications |
04/24/2013 | CN101605793B Azabicycloalkane derivatives, preparation thereof and use thereof in therapy |
04/24/2013 | CN101558071B Substituted quinazolines |
04/24/2013 | CN101535312B 吡咯并三嗪激酶抑制剂 Pyrrolotriazine kinase inhibitors |
04/24/2013 | CN101326188B Pyrimidin-4-yl-3,4-dihydro-2h-pyrrolo[1,2A]pyrazin-1-one compounds |
04/24/2013 | CN101305006B Compounds comprising short aminoalcohol chains and metal complexes for medical imaging |
04/23/2013 | US8426610 Intermediate compounds for the preparation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]-oxepino[4,5-c]pyrrole |
04/23/2013 | US8426588 Phenylalanine derivatives |
04/23/2013 | US8426583 Processes for preparing certain hexaazaisowurtzitanes and their use in preparing hexanitrohexaazaisowurtzitane |
04/23/2013 | US8426437 Pyrroloquinoline derivatives and their use as protein kinases inhibitors |
04/23/2013 | US8426428 EGFR kinase knockdown via electrophilically enhanced inhibitors |
04/23/2013 | CA2709202C Fused pyridine, pyrimidine and triazine compounds as cell cycle inhibitors |
04/23/2013 | CA2623047C 7-[2-[4-(6-fluoro-3-methyl-1,2-benzisoxazol-5-yl)-1-piperazinyl]ethyl]-2-(1-propynyl)-7h-pyrazolo-[4,3-e]-[1,2,4]-triazolo-[1,5-c]-pyrimidin-5 amine |
04/23/2013 | CA2610042C 2-oxo-1-pyrrolidine derivatives, processes for preparing them and their uses |
04/23/2013 | CA2549954C Derivatives of 1,4-diazabicyclo[3.2.1]octanecarboxamide, preparation method thereof and use of same in therapeutics |
04/23/2013 | CA2436245C Medicament for protection in radiotherapy |
04/18/2013 | WO2013056060A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
04/18/2013 | WO2013056015A1 Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors |
04/18/2013 | WO2013055987A1 Pyrrolobenzodiazepines and conjugates thereof |
04/18/2013 | WO2013055984A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
04/18/2013 | WO2013055897A1 8 - carbamoyl - 2 - (2,3- di substituted pyrid - 6 - yl) -1,2,3,4 -tetrahydroisoquinoline derivatives as apoptosis - inducing agents for the treatment of cancer and immune and autoimmune diseases |
04/18/2013 | WO2013055747A1 Methods to produce alkylated polycyclic guanidine compounds |
04/18/2013 | WO2013055645A1 5,7-substituted-imidazo[1,2-c]pyrimidines |
04/18/2013 | WO2013054291A1 Novel oxazine derivatives and their use in the treatment of disease |
04/18/2013 | WO2013054185A1 Pyrimidine and pyridine derivatives useful in therapy |
04/18/2013 | WO2013053942A1 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d] pyrimidine derivatives, their manufacture and their use as antiviral active substances |
04/18/2013 | WO2013053873A1 Pyrrolobenzodiazepines |
04/18/2013 | WO2013053872A1 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines |
04/18/2013 | WO2013053871A1 Pyrrolobenzodiazepines |
04/18/2013 | WO2013053690A1 Pde9i with imidazo pyrazinone backbone |
04/18/2013 | WO2013053657A1 Antiviral compounds |
04/18/2013 | WO2013053202A1 Pyrrolo pyrroledione-thenequinone compound, and preparation process and use thereof |
04/18/2013 | WO2013053045A1 Heterocyclic molecules as apoptosis inducers |
04/18/2013 | US20130096316 Novel Method for Preparation of Bisnorcymerine and Salts Thereof |
04/18/2013 | US20130096315 Certain chemical entities, compositions and methods |
04/18/2013 | US20130096302 Pyrrolopyrazines and pyrazolopyrazines useful as inhibitors of protein kinases |
04/18/2013 | US20130096146 Tricyclic Compounds Having Antimitotic and/or Antitumor Activity and Methods of Use Thereof |
04/18/2013 | US20130096144 Isoindolinone and pyrrolopyridinone derivatives as akt inhibitors |
04/18/2013 | US20130096129 Activators of class i histone deacetlyases (hdacs) and uses thereof |
04/18/2013 | US20130096128 Pyrazole compounds useful as protein kinase inhibitors |
04/18/2013 | US20130096118 Carboline carboxamide compounds useful as kinase inhibitors |
04/18/2013 | US20130096114 Pharmacokinetically improved compounds |
04/18/2013 | US20130096113 Heterocyclic compounds and methods of use thereof |
04/18/2013 | US20130096110 Pyrazolopyridine, Pyrazolopyrazine, Pyrazolopyrimidine, Pyrazolothiophene and Pyrazolothiazole Compounds as MGLUR4 Allosteric Potentiators, Compositions, and Methods of Treating Neurological Dysfunction |
04/18/2013 | US20130096109 Pyridone derivative having integrase inhibitory activity |
04/18/2013 | US20130095066 Compounds for the Treatment of Hepatitis C |
04/18/2013 | US20130095035 Polyanionic multivalent macromolecules for intracellular targeting of proliferation and protein synthesis |
04/18/2013 | DE102011116373A1 Preparing substituted amino-phenylamino-phenyl-pyrazolo(3,4-d)pyrimidine derivatives useful e.g. for treating picornavirus infection, comprises reacting substituted amino-phenylamino-pyrazole-carbonitrile compounds and benzamidine compounds |
04/18/2013 | DE102011054477A1 Verfahren zur katalytischen Heteroaromatenhydrierung Process for the catalytic Heteroaromatenhydrierung |
04/18/2013 | CA2851810A1 Substituted tetrahydroisoquinoline compounds as factor xia inhibitors |
04/18/2013 | CA2851623A1 5,7-substituted-imidazo[1,2-c]pyrimidines |
04/18/2013 | CA2851445A1 Novel oxazine derivatives and their use in the treatment of disease |
04/18/2013 | CA2851364A1 8-carbamoyl-2-(2,3-di substituted pyrid-6-yl)-1,2,3,4-tetrahydroisoquinoline derivatives as apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases |
04/18/2013 | CA2851155A1 Heterocyclic compounds and methods of use thereof |
04/18/2013 | CA2850439A1 4-amino-3-phenylamino-6-phenylpyrazolo[3,4-d]pyrimidine derivatives, their manufacture and use as antiviral agents |
04/18/2013 | CA2850264A1 Pyrrolobenzodiazepines |
04/18/2013 | CA2850103A1 Pyrrolobenzodiazepines |
04/18/2013 | CA2850096A1 Synthesis method and intermediates useful in the preparation of pyrrolobenzodiazepines |
04/18/2013 | CA2847083A1 Antiviral compounds |
04/17/2013 | CN103052639A 6-cycloalkyl-1, 5-dihydro-pyrazolo [3, 4-d] pyrimidin-4-one derivatives and their use as pde9a inhibitors |
04/17/2013 | CN103052638A Process for the preparation of dimiracetam |